GHP September 2016

70 | ghp September 2016 Deals Canadian Medical Technology Company LABORIE to Become New Subsidiary LABORIE was founded in 1967 and has grown organically and through acquisitions from a leading manufacturer of capital equipment for urodynamic testing into a fully-integrated medical device company with a market-leading position in urology and a rapidly growing gastroenterology business. LABORIE has an attractive, asset-light business model with a high share of its revenue derived from recurring sales of proprietary consumables. LABORIE’s global manufacturing, development and commercialization capabilities create a solid platform for growth through organic and non-organic expansion in core and adjacent markets, new geographies and further expansion beyond diagnostics into therapeutic products. LABORIE will continue to be run by its cur- rent management team, which will remain part-own- ers of the company. LABORIE will be the most recent addition to the Patricia Industries portfolio of high-quality growth companies, whose other healthcare holdings include Mölnlycke Health Care, Permobil, Aleris and Braun- Ability. Fiscal year 2016 (ending March) sales were USD 117 m. with strong profitability. Additional financial information about LABORIE, including the acquisi- tion price, will be disclosed upon completion of the acquisition. “LABORIE will be a strong addition to Patricia Indus- tries and marks another step in our strategy to contin- ue to build our portfolio of wholly-owned subsidiaries in the Nordics and in North America”, comments Investor CEO Johan Forssell. The acquisition of LABORIE is Patricia Industries’ first Canadian acquisition and the second in North Amer- ica since the inception of Patricia Industries in 2015. LABORIE will be a new subsidiary managed out of the New York office. “LABORIE has successfully developed into a high-quality and highly regarded provider of diag- nostics products that help a vast number of people improve their daily lives, and its culture and values fit very well with those of Patricia Industries and Investor. Drawing from our experience and global network within healthcare products and services, we believe that Patricia Industries is well-positioned to support LABORIE in its continued progress in a number of areas. We look forward to working together with LABORIE’s dedicated management and employees to advance the company’s position further, to the benefit of its customers, employees and owners”, comments Börje Ekholm, CEO of Patricia Industries. “We are excited to partner with Patricia Industries for the next phase of our growth”, comments LABORIE President and CEO Brian Ellacott. “LABORIE is the global leader in improving quality of life for patients suffering from urologic and gastroenterology disorders. This investment will allow us to continue to expand our global footprint as well as develop and bring to market innovative new products that will improve outcomes for patients.” The acquisition is subject to approval by the relevant competition authorities. Closing is expected during the third quarter 2016. Patricia Industries, a part of Investor AB, makes control investments in best-in-class companies with strong market positions, brands and corporate cul- tures within industries positioned for secular growth. Our ambition is to be the sole owner of our compa- nies, together with strong management teams and boards. We invest with an indefinite holding period, and focus on building durable value and capturing organic and non-organic growth opportunities. LABORIE is an industry-leading manufacturer and supplier of pelvic health and gastrointestinal equip- ment and consumables. Since its founding in 1967, LABORIE has been committed to delivering innovative, complete solutions that provide better diagnostics and treatment outcomes to patients worldwide. LABORIE is a portfolio company of Audax Private Equity. For more information, visit Patricia Industries, a part of Investor AB, has signed an agree- ment with Audax Private Equity to acquire the Canadian medical technology company LABORIE, which focuses on the diagnosis and treatment of urologic and gastrointestinal disorders that affect the daily lives of millions.